TEV-45779
TV45779-IMB-30086
Phase 3 other completed
Quick answer
TEV-45779 for Chronic Urticaria is a Phase 3 program (other) at Teva Pharma GmbH with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Teva Pharma GmbH
- Indication
- Chronic Urticaria
- Phase
- Phase 3
- Modality
- other
- Status
- completed